IL91261A - Anti-inflammatory pharmaceutical preparations containing carbinoolimidazoles - Google Patents

Anti-inflammatory pharmaceutical preparations containing carbinoolimidazoles

Info

Publication number
IL91261A
IL91261A IL9126189A IL9126189A IL91261A IL 91261 A IL91261 A IL 91261A IL 9126189 A IL9126189 A IL 9126189A IL 9126189 A IL9126189 A IL 9126189A IL 91261 A IL91261 A IL 91261A
Authority
IL
Israel
Prior art keywords
formula
alkyl
composition
compounds
prepared
Prior art date
Application number
IL9126189A
Other languages
English (en)
Hebrew (he)
Other versions
IL91261A0 (en
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of IL91261A0 publication Critical patent/IL91261A0/xx
Publication of IL91261A publication Critical patent/IL91261A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL9126189A 1988-08-10 1989-08-09 Anti-inflammatory pharmaceutical preparations containing carbinoolimidazoles IL91261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/230,448 US4859693A (en) 1988-08-10 1988-08-10 Antiinflammatory carbinoloimidazoles

Publications (2)

Publication Number Publication Date
IL91261A0 IL91261A0 (en) 1990-03-19
IL91261A true IL91261A (en) 1994-01-25

Family

ID=22865262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9126189A IL91261A (en) 1988-08-10 1989-08-09 Anti-inflammatory pharmaceutical preparations containing carbinoolimidazoles

Country Status (18)

Country Link
US (1) US4859693A (de)
EP (1) EP0354539B1 (de)
JP (1) JPH0692301B2 (de)
KR (1) KR900002773A (de)
AT (1) ATE120643T1 (de)
AU (1) AU633261B2 (de)
CA (1) CA1336964C (de)
DE (1) DE68922038T2 (de)
DK (1) DK390589A (de)
ES (1) ES2070873T3 (de)
HU (1) HU207794B (de)
IL (1) IL91261A (de)
MX (1) MX166479B (de)
MY (1) MY104099A (de)
NO (1) NO893213L (de)
NZ (1) NZ230247A (de)
PT (1) PT91427B (de)
ZA (1) ZA896121B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049570A (en) * 1990-01-23 1991-09-17 Du Pont Merck Pharmaceutical Company Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE44186B1 (en) * 1975-12-03 1981-09-09 Ici Ltd 1,2,4-triazolyl alkanols and their use as pesticides
JPS6048486B2 (ja) * 1976-01-01 1985-10-28 木場 常義 抗リウマチ剤
DE2623129C3 (de) * 1976-05-22 1980-04-10 Nordmark-Werke Gmbh, 2000 Hamburg U-Diphenyl-3-(imidazol-l-yl) -propan-2-ole, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4413003A (en) * 1977-07-29 1983-11-01 Rohm And Haas Company β-Hydroxyarylethylimidazoles
DE2851116A1 (de) * 1978-11-25 1980-06-12 Bayer Ag Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2851143A1 (de) * 1978-11-25 1980-06-04 Bayer Ag Fluorenyl-azolylmethyl-carbinole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2912288A1 (de) * 1979-03-28 1980-10-09 Bayer Ag Verfahren zur herstellung von hydroxyethyl-azolen
DE2920375A1 (de) * 1979-05-19 1980-11-20 Bayer Ag Fungizide mittel, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
US4414210A (en) * 1979-10-02 1983-11-08 Rohm And Haas Company 2-Hydroxyarylethyltriazole fungicides
GB2068228B (en) * 1980-01-24 1984-02-29 Janssen Pharmaceutica Nv Anti-microbial compositions for the topical treatment of acne vulgaris
DE3280075D1 (de) * 1981-11-27 1990-02-08 Ciba Geigy Ag Mikrobizide triazolyl-ethyl-aether.
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
DE3579347D1 (de) * 1984-04-05 1990-10-04 Ici Plc Azolylpropanole.
US4766140A (en) * 1984-06-18 1988-08-23 Eli Lilly And Company Method of inhibiting aromatase
DE102007058724B3 (de) * 2007-12-06 2009-05-14 Fujitsu Siemens Computers Gmbh Datenverarbeitungssystem

Also Published As

Publication number Publication date
DE68922038D1 (de) 1995-05-11
HU207794B (en) 1993-06-28
EP0354539A2 (de) 1990-02-14
CA1336964C (en) 1995-09-12
AU633261B2 (en) 1993-01-28
NO893213L (no) 1990-02-12
PT91427A (pt) 1990-03-08
ATE120643T1 (de) 1995-04-15
NO893213D0 (no) 1989-08-09
HUT51895A (en) 1990-06-28
AU3943989A (en) 1990-02-15
ES2070873T3 (es) 1995-06-16
DK390589D0 (da) 1989-08-09
NZ230247A (en) 1991-12-23
EP0354539B1 (de) 1995-04-05
MY104099A (en) 1993-11-30
PT91427B (pt) 1995-05-31
EP0354539A3 (de) 1991-11-13
DK390589A (da) 1990-02-11
MX166479B (es) 1993-01-12
ZA896121B (en) 1991-04-24
IL91261A0 (en) 1990-03-19
KR900002773A (ko) 1990-03-23
US4859693A (en) 1989-08-22
DE68922038T2 (de) 1995-08-03
JPH0692301B2 (ja) 1994-11-16
JPH0291021A (ja) 1990-03-30

Similar Documents

Publication Publication Date Title
KR100386491B1 (ko) 항진균제,이를위한화합물및이의제조방법
US4776877A (en) Triazolyl-alkanones or triazolyl-alkanols
US4156008A (en) 1-(4-Alkyl-2-aryl-1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4689341A (en) Antiarrhythmic imidazoles
FI87774B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva aralkylimidazolderivat
US4616026A (en) Antifungal 2-aryl-1,1-difluoro-3-(1H-1,2,4-triazol-1-yl)2-propanols
FI82933B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara 1-aryl-1-fluoralkyl-2-(1h-1,2,4-triazol-1 -yl) etanoler.
US4760149A (en) Asymmetrically modified boron hydride type compound, a production method thereof, and a method for producing an optically active alcohol derivative by the use thereof
HU194187B (en) Process for producing triazol compounds and pharmaceutical compositions containing them
FI86176C (fi) Foerfarande foer framstaellning av ett vid behandling av svampinfektioner anvaendbart bis-triazolderivat och en i foerfarandet anvaendbar mellanprodukt.
BG98812A (bg) 1-(арилалкил-аминоалкил)имидазоли,метод за получаване и използване като терапевтични средства
JPS6028820B2 (ja) 置換ｎ‐アルキルイミダゾール誘導体
US4780471A (en) Fungicidal azole derivatives
IL91261A (en) Anti-inflammatory pharmaceutical preparations containing carbinoolimidazoles
HU180139B (en) Process for preparing 1-phenyl-2-amino-ethanol derivatives
EP0612716B1 (de) Verfahren zur Herstellung von einem optisch reinen Aminoalkohol
US4742077A (en) Bicyclic allylether derivatives, processes for their production and their use
JPH01106860A (ja) Ｎ−置換３−アリール−ピロリジン誘導体、該化合物の製法並びに該化合物を含有する殺菌剤及び殺菌法
US4749793A (en) 5-substituted-3-phenyl-3-[1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl]-2-benzylisoxazolidines (ir 3011)
JPS61271280A (ja) 新規アゾ−ル誘導体、その製造方法と用途
KR100418128B1 (ko) 인간및수의학적용도의항진균활성을갖는아졸화합물
HU201745B (en) Process for producing 1-(1-aryl-2-hydroxyethyl)-imidazoles, their salts and pharmaceutical compositions comprising such compounds
JPH01102065A (ja) 抗糸状菌剤
DK166880B1 (da) Triazolforbindelser og farmaceutisk acceptable salte deraf, farmaceutisk praeparat indeholdende disse og forbindelserne til terapeutisk anvendelse, isaer som antifungalt middel
HU185887B (en) Compositions containing 1-imidazolyl-bethan derivatives as active agents, and process for producing the active agents

Legal Events

Date Code Title Description
RH Patent void